OVACOME
Registered Charity No. 1159682
REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 September 2025

OVACOME
Legal and Administrative Information
Registered Charity Number. 1159682
Trustees (Executive Committee Members)
The trustees who served during the period and up to the date of signing of this report were:
Cathryn Hughes (Chairl
John Paul McKew ITreasurerl
Marta Wojcik Iresigned l May 20261
Sean Kehoe IHead of Expert Advisory Panel)
Victoria Von Wachter
Lesley Sage
Adrian Dickinson
Samixa Bakul Shah
Richard Riley
Michelle Hill1Secretsryl
CEO
Victoria Clare
Patrons
Jenny Agutter
Lady Adele Sewell, M.B.E
Principal Office
52-54 Featherstone Street
London
ECIY 8RT
International Ambassador
Manisha Koirala
Independent Examiner
Kevin Fisher BA FCA CTA
Kingston Burrows Audit Ltd
308 Ewell Road
Surbitton
Surrey, KT6 7AL
Bankers
CAF Bank Limited
25 Kings Hill Avenue
Kings Hill
West Malling
Kent ME19 4JQ

OVACOME
Trustees Report
For the year ended 30 September 2025
The trustees are pleased to present their report together with the financial statements of the charity
for the year ended 30 September 2025. Legal and administrative information set out on page 2
forms part of this report. The financial ststements have been prepared in accordance with the
accounting policie5 set out in note I to the accounts and comply with the charity's trust deed, the
Charities Act 2011 and Statement of Recommended Practice: Accounting and Reporting Charities
preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK
and the Republic of Ireland IFRS102}, issued in October 2019.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Legal structure of the charity
The charity is constituted as a charitable incorporated organisation ICIOI. Ovacome was entered on
the Register of Charities No 1159682 on 18 December 2014 and is governed by its constitution
adopted also on 18 December 2014. Ovacome was originally established in 1996 as a charity on
the Register of Charities and a Itd company at Companies House. It was then converted to a CIO
in 2014.
Ovacome has a board of 10 volunteer trustees. All trustees are individuals who have been
personally affected by the disease or clinicians who specialise in ovarian cancer IOC).
Recruitment and induction of trustees
Trustees are recruited for their knowledge. skills. networks and experience.
Ovacome is unique within the gynaecology oncology sector as the board is made up of trustees
whose lives have been directly affected by ovarian cancer. In addition, Ov3come was established
as a membership charity. Whilst anyone can access our support without being a member, it is free
to become a member, and members have certain rights and benefits conferred upon them.
Members can vote at the Annual General Meeting IAGMI and have the opportunity to participate
in consultstion to set the priorities of the charity and inform future strategic direction of service
provision.
Trustees are recruited following 2 periodic trustee board skills audit. Areas for development are
identified and then recruitment adverts are circulated among our membership and more widely.
All new trustees are given background information about the charity, are advised about their
responsibilities and given an ir)duction into the work of the charity. The training needs of the
trustees are reviewed, and training is sourced where deemed necessary and appropriate. The full
recruitment proce55 tske5 between 6-9 months.
Management and administration
The Executive Committee. members of which constitute trustees for the purpose of Charity
legislation. administers Ovacome. The Chair. officers 3nd other trustees are appointed lor
reappointed) at the AGM. No external bodies have the power to appoint trustees. and the Executive
Committee is ultimately responsible for the charity. The names of trustees who have served since
l October 2024 are set out under Legal and Administrative Information on page 2 of this document.
The trustees meet via online conference calls monthly to review progress and support development
of the charity in line with our organisational aims. The Chief Executive and staff team manage the
day to day running of Ovacome and operational delivery based on the strategic direction agreed by
the trustees.

OVACOME
Trustees Report
For the year ended 30 September 2025
Remuneration of Key Management Personnel
The remuneratior) of the charity's key management personnel is set by the Executive Committee,
taking into account the charity's financial position and the amount paid for similar roles in
comparable organisations.
OBJECTIVES AND ACTIVITIES
Currently our head office is in London. As of 30 September 2025 there are 17 staff110 full time, 7
part timel. Ovacome has 88 registered and active volunteers at the time of writing.
The charity serrfes:
People who have been diagnosed with ovarian cancer
Family members of those diagnosed
Those who may be at risk of OC
The general public (by raising awareness of the symptoms}
The research community by funding opportunities for better understanding and curing
ovarian cancer
Clinicians specialising in ovarian cancer
Health care providers who may be involved in diagnosing and treating ovarian cancer
The number of ovarian cancer cases in the UK is not thought to be increasing signif icantly. Around
7,500 new cases are diagnosed each year and this number has remained constsnt for some time.
For women born after 1960. 1 in 50 are diagnosed with ovarian cancer in their lifetime. But still
there is little awareness of the signs and symptoms of the disease among the public and no effective
screening tool. This means that most people are diagnosed at the later stages of the disease.
The need for Ovacome remains constsnL Until all people are aware of the symptoms and able to
access equitable treatment. support 2nd information Ovacome will continue to work to meet the
needs of all those affected by the disease. Ovacome works across the UK via our support and
information services. and we provide face to face support and work with local charities to improve
the support available to all affected by ovarian cancer- regardless of where they live.
Our potential reach. One study suggested that in 2010, 41,000 women were living in the UK with
ovarian cancer. They will vary hugely in health, stages of the disease and their support needs. In
more recent years there have been significant advances in treatment options and trials access in
the UK. If we assume that there are now more women living with the disease than in 2010 and
accept that it is our role to support women with ovarian cancer. their family members. the clinicians
that treat them, or those at risk of the disease. then our potential reach is substantially wider than
the numbers currently accessing our services. Since 2018 we have worked actively with partner
organisations and our members to become more representative of the UK population, with a
diverse and mutually supportive community. We have made all our services more accessible and
inclusive and will continue to work to do so. We have actively challenged and changed policy to
reduce the inequalitie5 that many face when acce55ing diagnosis, treatment or support.
Charity activities
Ovacome has provided a wide range of expert services free to all those affected by ovarian cancer
since 1996.
We do thi5 by:
Supporting those affected by ovarian can￿r with a friendly community

OVACOME
Trustees Report
For the year ended 30 September 2025
Providing opportunities for those affected by ovarian cancer to meet and share their
experiences
Ovacome does this through both face-to-face and online events. via support groups
(including local hybrid groups}- online workshops- online discussion forum,. hybrid members
day and health and wellbeing events
Raising awareness of ovarian cancer and its symptoms
Promoting an understanding of the signs and symptoms of ovarian cancer and the patient
experience, including tsrgeted messaging to underserved groups who are overlooked in
mainstream awareness campaigns
Campaigning to raise awareness of signs and symptoms using our research based B.E.A.T.
campaign which supports early diagnosis
Educating clinicians in the symptoms and impact of ovariar) cancer
Remaining at the forefront of knowledge and innovation in the diagnosis, treatment and
communication in all matters related to ovarian cancer
Working with community groups and other organisations to undertake targeted campaigns
in a wide range of formats and languages to ensure that those who face barriers to accessing
diagnosi5 are more aware of the 5ymptom5 of the disease
Infonning and educating people about the disease
Providing evidence-based. up to date information through our website, magazine,
information booklets and across support service platforms
Building our community networks across the UK to ensure this information is reaching all
who need it
Providing information as requested by our members in a variety of formats and languages,
as required
Working with our world c13ss board of expert advisors to ensure that f3Ctually accurate and
up to date information is provided in a way that people can understand
Ensuring empathy, sensitivity and discretion in every stakeholder interaction
Influencing and advocating
Advocating for prevention strategies, research and equity of treatment, experience, and
outcomes for all those diagnosed with ovarian cancer
Identify and lead change to address the health inequalities in access to support for all
Collaborating with other organisations to ensure the voices of the people that we represent
are considered by decision-makers
Fund research, including patient perspective research. as appropriate
Providing training and information sessions for clinicians on the symptoms of the disease
and also on the patient experience
Ensuring that. wherever possible. patient voice is incorporated into decision making at a
national and local level
Constantly monitoring our Suc￿5 in achieving our aims
Regularly seek the views of our membership and the wider community to provide feedback
on our actions and the impact they are having

OVACOME
Trustees Report
For the year ended 30 September 2025
Regularly review our actions against those providing similar services or partnership
organisations
ACHIEVEMENT AND PERFORMANCE
Review of the year
We continue to see steady demand for our support services 3cross all our support channels. We
provided direct support to 4.779 people through our support line, events. 3nd support groups. Our
qualified and experienced support stsff provide up-to-date information regarding various areas of
OC, including treatments and trials, risk, livir)g with the disease, and symptom management, whilst
also providing much needed emotional support. The community we support varies, from those
recently diagnosed, to family and friends concerned about loved ones, people needing information
about their familial risk of being diagnosed with the disease, to those going through treatment, a
recurrence, or end of life planning. Our team are available every step of the way, and we are a
lifeline for thousands. Our popular online forum remained busy, running 24 hours a day, 7 days a
week 2nd with membership reaching 19.325 members by the end of the financial year.
During the year we were able to scale up our face to face events. providing support events in the
following towns and cities:
London
Liverpool
Bim)ingham
Leeds
Newcastle
Bristol
Bath
Southampton
Cheltenham
Bournemouth
Norwich
Coventry
Belfast
Our team work closely with our community and listen to their needs - as a result we continued to
provide regular weekly online community sessions, through which people are able to relax and
participate in an activity with others who have been diagnosed with the disease. This provides
invaluable community building opportunities and reduces loneliness, 3nxiety and isolation for many.
A further series of webinars and workshops ran throughout the year, given by experts in their own
field of work and particularly by members of our expert advisory panel. We are grateful to all those
who have given their time ar)d expertise overthe course of the yearto support our community. The
topics for these clinical and medical updates are requested by members of our community and the
attendees can ask questions of experts. Many of these tslks and presentstions are recorded and
shared on our YouTube channel, this is helpful to many thousands of people and we are seeing an
increasing number of healthcare providers sharing these webinar resources with their patients or
using them 35 training tools for healthcare professionals. Over the course of the year our YouTube
videos were watched over 34.000 times with over 2.600 hours of viewing.
At the request of our members we have continued to run expert support groups over the course of
the year.

OVACOME
Trustees Report
For the year ended 30 September 2025
We continued to run local support groups and to support other gynaecology oncology groups
already in existence with grants. facilitation and information or specialist speakers. We also provide
3 resource for anyone setting up an independent ovarian cancer support group and can provide
information, grants, SUPPOrt and speaker5 to those committed to providing support at a local level.
Our work ha5 continued within Ovacome to reduce barriers to accessing our services and to
improve inclusivity. This has led to our community becoming more diverse. We continue our work
to ensure that all members of our community are 5UPPOrted to access diagnoses, treatment and
support in a culturally appropriate and accessible way.
Our support team can provide interpreters in over 150 languages. We co-produced videos in 8
languages to help people understand what happens after a diagnosis of ovarian cancer. these have
been reached by over 360.000 people to date. Over 780.CKK) people who face health inequalities
were given targeted information about the signs and symptoms of the disease. Over 100
community groups and charities across the UK partnered with us to reach those facing barriers to
accessing diagnosis, treatment and supporL
Information provision and awareness raising
Our Expert Advisory Panel of professional volunteers now numbers 34. This panel is made up of
top clinicians and experts in the field with a variety of specialities, they continue to give the charity
access to expert advice and influer)ce. We remain particularly grateful to the professionals, who
give their time voluntarily.
Our Patient Experience in Practice IPEPI training sessions deliver valuable information in an
impactful and personalised way and focus on the lived experience of those diagnosed with the
disease. These sessions are subdivided into:
STS sessions - Survivors Teaching Students. This trains medical students to recognise the
signs and symptoms of ovarian cancer using the lived experience of those diagnosed with
the disease.
EPE sessions
Enhancing Patient Experience. Through which we provide specific
information to medical oncologists, surgeons and specialist nurses - all involved in treating
those with ovarian cancer. These training sessions provide specialist information on the
lived experience of those affected by ovarian cancer and facing barriers to diagnosis,
treatment and supporL
Through the two programmes 1,750 healthcare professionals were trained to better recognise the
symptoms of ovarian cancer and given help to improve experience for their patients.
FUNDRAISING
A huge thank you to all the incredible people who have supported our work through donations,
fundraising and unwavering encouragement. Your generosity is the reason we are able to continue
providing life-changing support and vitsl infom)ation to those affected by ovarian cancer.
Every year, our supporters take on extraordinary challenges for Ovacome. In 2025, 17 runners
represented Team Ovacome at the London Marathon, raising a phenomenal £54,534.95
and
counting - making it our highest London Marathon team total ever.

OVACOME
Trustees Report
For the year ended 30 September 2025
Davina Budesha, alongside 21 family members and friends, took part in the Manchester Half
Marathon, raising an outstanding £10.029.
Phil Soderberg and friends undertook yet another rem3rk3ble challenge, raising a stsggering
£40.225 through a 300km Milan to Zurich team cycle ride completed in just 24 hours. in memory
of Debbie Baldwin. We were also delighted to see the return of the fourth annual Debbie Baldwin
Gala, where friends and family came together to raise £24,379.95.
In September, the wonderful Touch of Teal event took place at the May Fair Hotel, raising an
amazing £24,001. Apricot Clothing continued their valued support throughout Ovarian Cancer
Aw3reness Month and generously donated £IO.IXK) towards our Big Give campaign.
The monumer)tal efforts of our community are truly humbling. We are deeply grateful not or)ly for
the funds raised. but31soforthe creativity. determination and compassion shown byeveryone who
supports our work.
We would like to thank all our amazing supporters for their kindness and generosity - from those
who tske on incredible challenges acrossthe UK, to those who organise inspiring events, and those
who bake, sew and knit items to raise vital funds for our services.
FINANCIAL REVIEW
Gross income and expenditure figures for the year ended 30 September 2025 were income of
£877.58412024 - £744.8411 and expenditure of £1,045.730 {2024 - £955.7181. giving an overall
deficit of £168,14612024 - deficit £210.8771. Restricted Funds of £419.681 were received during
the year, of which £356,661 (including £56.140 unspent funds brought forward this year and fund
transfer £2,184) were expended, leaving a surplus of £63,020 and cumulative £121,344 carry
forward into 2025126.
As regards Desigr)ated Funds, the remaining Designated Funds relate to the Research Fund at the
University of Birmingham.
Resenie policy
It is the trustees, aim to hold total reseNes equating to a period of totsl expenditure of minimum
three months in order to ensure continued financial security 3nd to provide for contingencies.
Ovacome holds certain funds in designated and restricted funds for designated projects. Ov3come
maintains relationships with beneficiaries, in some cases, for many years. To this end it is important
that Ovacome maintains a healthy balance of reserves.
On 30 September 2025 the balance of totsl Funds stood at £320,￿8. Total expenditure in 2024-
25 amounted to £1,045.730 so the balance at the year-end meets the three month reserves policy.
The trustees have considered the current level of reserves and determined that this level is
appropriate.
Risk management
The trustees actively review the major risks which the charity faces on a regular basis by maintaining
an up to date risk register report. The risk register is regularly presented to the trustees and they
input within their areas of specialism. The trustees believe that maintaining reserves at adequate
levels, combined with an annual review of the controls over key financial systems will provide
suff icient resources in the event of adverse conditions. The Trustees have also examined other

OVACOME
Trustees Report
For the year ended 30 September 2025
operational and business risks faced by the charity and believe that the systems in place to mitigate
significant risks offer the trust adequate protection.
Going concern
The trustees believe that by maintaining reseNes at the levels required by the reserves policy and
by regularly reviewing the charity's key financial systems, they can ensure that suff icient resources
3re in place to mitigate significant risks. In the light of Covid-19. the trustees have examined the
operational and business risks faced by the charity and believe that the systems and reserves in
place offer the charity adequate protection and ensure its continuance as a going concern.
Public benefit
Ovacome has referred to the Charity Commission's general guidance on public benefit. including
the guidance 'public benefit: running a charity IPB21.' when reviewing its aims and objectives and in
planning f uture activities. In particular. the trustees consider how all activities contribute to its aims
and objectives and believe that a clear benefit to the public is demonstrated. This is described in
more detail throughout the Review of the Period.
PLAN FOR FUTURE PERIODS
Ovacome will continue our work to meet the needs of anyone affected by ovarian cancer in the
UK. Our plan5 are outlined in our strategy, we will continue to deliver the services and projects as
listed within our report above.

OVACOME
Trustees Report
For the year ended 30 September 2025
STATEMENT OF EXECUTIVE COMMIThEE'S RESPONSIBILITIES
The trustees are responsible for preparing the trustees, report and the Financial Statements in
accordance with applicable law and United Kingdom Accounting Standards (United Kingdom
Generally Accepted Accounting Practice).
The law applicable to charities in England & Wales requires the trustees to prepare Financial
Statements for each f inancial year which give a true and fair view of the stste of affairs of the
charity and of its income and expenditure for that period. In preparing these Financial Statements,
the trustees are required to-
select suitable accounting policies and then apply them consistently
observe the methods and principles of the Charities SORP 2019 IFRS 1021
make judgements and estimates that are reasonable and prudent
prepare the Financial Statements on the going concern basis unless It is inappropriate
to presume that the charity will continue in operation
The trustees are responsible for keeping proper accounting records that disclose with reasonable
accuracy at any time the financi31 position of the charity and enable them to ensure that the
Financial Ststements comply with the Charities Act 2011 and the Charity (Accounts and Reports)
Regulations. They are also responsible for safeguarding the assets of the charity and hence taking
reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by the Executive Committee and authorised for issue on 22 April 2026 and signed on its
behalf by.
Cathryn Hughes
Trustee and Chair
10

OVACOME
Independent Examiner's Report to the Trustees of Ovacome
I report to the Charity trustees on my examination of the accounts of Ovacome for the year ended
30 September 2025, which are set out on page 12 to 24.
Responsibilities and basis of report
As the charity's trustees you are responsible for the preparation of the accounts in accordance with
the requirements of the Charities Act 20111'the ACV).
I report in respect of my examination of the charity's accounts carried out under section 145 of the
Act and in carrying out my examination I have followed all the applicable Directions given by the
Charity Commission under section 1451511bl of the ACL
Independent examiner's statement
Since the chariws gross income exceeded £250,LK)O your examiner must be a member of a body
listed in section 145 of the Act. I confirm that l am qualified to undertske the examination because
l am a member of the Institute of Chartered Accountants in England and Wales. which is one of
the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in
connectior) with the examination giving me cause to believe that in any material respect:
l. accounting records were not kept in respect of the Charity as required by section 130 of
the Act.. or
2. the accounts do not accord with those records- or
3. the accounts do not comply with the applicable requirements concerning the form and
content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other
than any requirement that the accounts give a 'true and fair view, which is not a matter
considered as part of an independent examination
I have no concerns and have come across no other matters in connection with the examination to
which attention should be drawn in this report in order to enable a proper understanding of the
accounts to be reached.
Kevin Fisher BA FCA CTA (Senior Statutory Auditor)
For and on behalf of Kingston Burrows Audit Ltd
ststutory Auditors
308 Ewell Road
Surbiton
Surrey, KT6 7AL
Date: 21 May 2026
11

OVACOME
Statement of Cash Flows for the year ended 30 September 2025
Unrestricted Restricted Total Funds Total Funds
Funds
Funds
2025
2024
Notes
INCOME
Donations and legacies
Charitable activitie5 - Fundraising
Investment income
193,469
256.239
8.195
400,879
18.802
594,348
275.041
8,195
452,798
281.652
10,391
Total Income
457.903
419.681
877.584
744,841
EXPENDITURE
Fundraising expenditure
Charitable activities
199.578
489.491
199,578
846,152
151,698
804,020
356,661
Totsl Expenditure
689,069
356,661 1,045,730
955,718
Net incomellexpenditurel for the year
1231,1661
63,020 1168,1461 1210,8771
Transfer between funds
12.1841
2.184
Net Movement in Funds
1233.3501
65.204
1168,1461 1210.8771
Reconciliation of funds:
Funds brought forward
432.014
56.140
488.154
699.031
Funds canied ft)tward
198,664
121,344
320,008
488,154
The notes on page 16 to 24 form part of these financial statements
12

OVACOME
Statement of Financial Activities
For the year ended 30 September 2025
Analysis of prioryear totsl fund.
Unrestricted Restricted Totsl Funds
Funds
Funds
2024
Notes
INCOMEand ENDOWMENT
Donations and legacies
Charitable activities - Fundraising
Investment income
236.496
248.549
10.391
216,302. 452,798
33,103. 281,652
10,391
Totsl Income
495.436
249,405
744B41
EXPENDITURE
Fundraising expenditure
Charitable activities
151.698
525.107
151,698
278.913. 804,020
Totsl Expenditure
67&805
278,913
955,718
Net incomellexpenditurel forthe year
1181.3691 129.5081 1210,877)
Transfer between funds
Net Movementin Funds
1181.3691 129.5081 1210,877)
Reconciliation of funds:
Funds brought forward
613.383
85,648
699,031
Fund5 carried forward
432.014
56,140
488,154
13

OVACOME
Balance Sheet
As at 30 September 2025
2025
2024
Notes
FIXED Ass￿5
Tangible fixed 355ets
974
974
4.522
4,522
CURRENT ASSETS
Stock
Debtors
Cash at bank and in hand..
8.917
15.090
355.172
379.179
9,739
11,179
586,230
607,148
CREDITORS-. amounts falling due in one
160.1451
1123,5161
NET CURRENT ASSETS
319.034
483,632
NET ASSETS TOTALS
320,Crf)8
488,154
THE FUNDS OF THE CHARITY
INCOME FUNDS
Restricted funds
Unrestricted funds:
General fund
Designated funds
io
121,344
56,140
161.899
36.765
395,249
36,765
198.664
432.014
320,Crf)8
488,154
Approved by the Executive Committee and authorized for issue on 22 April 2026 and signed on
its behalf by-
John Paul McKew
Treasurer and Trustee
The notes on page 16 to 24 form part of these financial statement
14

OVACOME
Statement of Cash Flows for the year ended 30 September 2025
2025
2024
Notes
Cash flow from operating activtties
Net cash provided by operating activities
{239,253)
1131,571)
Cash flow from investing activities
Investment income
Purchase of fixed assets
8.195
10,391
11,153
Net cash prowded by investing activities
8.195
9,238
Change in cash and cash equivalents in the year
1231.058)
1122.333)
Cash and cash equivalents at l Oct 2024
586,230
708,563
Cash and cash equivalents at 30th Sep 2025
355,172
586,230
Notes to the cash flow statement
reconciliation of net movement in funds to net cash flow
2025
2024
from operating activities
Net income/lexpenditurel for the year Ibefore investment
Depreciation charge
Investment Income
Decrease/lincreasel in stock
Decrease/lincreasel in debtors
IDecreasellincrease in creditors
1168,1461
3,548
18,1951
822
13.9111
163.3711
1210,8771
1,468
110,3911
2,726
85,503
Net cash provided by operating activities
239,253
131,571
B - Analysis of cash and cash equivalents
Cash at bank and in hand
Closing balance of Cash in hand and Bank
355.172
586,230
Total cash and cash equivalents
355.172
586,230
The notes on page 16 to 24 form part of these financial ststements
15

OVACOME
Notes to the accounts for the year ended 30 September 2025
l Accounting Policies
Basis of preparation
The financial ststements have been prepared on a going concern basis under the historical cost
convention.
The financial statements have been prepared in accordance with the Financial Reporting Standard
applicable in the UK and Republic of Ireland IFRS 1021. The Charity is a public benefit entity for the
purposes of FRS 102 and therefore the Charity also prepares its financial statements in accordance
with the Statement of Recommended Practice applicable to charities preparing their accounts in
accordance with the Financial Reporting Stsndard applicable in the UK and Republic of Ireland (The
FRS 102 Charities SORPI issued in October 2019 and the Charities Act 2011.
The financial statements are prepared in sterling. which is the functional currency of the charity.
Monetary amounts in these financial ststements are rounded to the nearest pound.
Going concern
The trustees have assessed whether the use of the going concern basis is appropriate and have
considered possible events or conditions that might cast significant doubt on the ability of the
charity to continue as a going concern. The trustees have made this assessment for 3 period of at
least one year from the date of approval of the financial ststements. In particular the trustees have
considered the charity's forecasts and projections and have tsken account of pressures on donation
and event income. After making enquirie5 the trustees have concluded that there is a reasonable
expectation that the charity has adequate resources to continue in operational existence for the
foreseeable future. The charity therefore continues to adopt the going concern basis in preparing
its f inancial statements.
Income Recognition
All income is recognised when there is entitlement to the funds, the receipt is probable and the
amount can be measured reliably. Income is recognised in the year to which it relates and on an
accruals basis. Legacies are included when the legacy is received or when the charity is notified of
an impending distribution which can be quantified and receipt is probable. whichever is the earlier.
Recoverable taxation is accounted for on 3n accruals basis.
Expenditure
Expenditure is accounted for on an accruals basis allocated directly to the expenditure headings as
far as practically possible to reflect the activities of the charity- Charitsble activities comprise direct
expenditure including direct staff costs attributable to the activity.
Employee benefits
i. Short temi benefits
Short term benef its. including holiday pay and other similar non-monetary benefits, are recognised
as an expense in the period in which the service is received.
ii. Pensions
Ovacome operates a defined contribution plan for its employees. These contributions are
recognised as an expense when they are due. Amounts not paid are shown in accruals in the
balance sheet.
Fund Accounting
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by
the donor or are raised by the charity for specific restricted purposes.
16

OVACOME
Notes to the accounts for the year ended 30 September 2025
Unrestricted funds are funds which are available for use at the discretion of the trustees in
furtherance of the general objerts of the charity-
Designated funds are funds which are available for use at the discretion of the trustees but have
been earmarked by them for a specific purpose.
Fixed Assets and Depreciation
All assets costing more than £l.C((i are capitslised.
Depreciation on fixed assets is provided at rates estimated to write off the cost, less estimated
residual value, of each asset over its expected useful economic life as follows-
Computer Equipment and Mascot Costume 3 years {straight line basis)
Stock
Stocks of Ovacome fundraising merchandise are ststed at the lower of cost and net realisable value.
Debtors and Creditors
Debtors and Creditors with no stated interest rate and receivable or payable within one year are
recorded at transaction price. Anylosses arising from impairments are recognised in expenditure.
Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with bank and other short-
term liquid investments with original maturities of three months or less.
Critical accounting estimates and areas of judgment
In the view of the trustees in applying the accounting policies adopted, no judgements were
required that have a significant effect on the amounts recognised in the financial statements nor
do any estimates or assumptions made carry a significant risk of material adjustment in the next
financial year.
Leases
Operating lease rentals are charged to the Statement of Financial Activities on a straight-line basis
over the period of the lease.
2 Donation and Legacies
Unrestricted
Funds
Restricted Total Funds Total Fund5
Funds
2025
2024
Donations
Legacies
152,445
41,024
345,341
55,538
497,786
96,562
415,298
37,500
193.469
400,879
594,348
452,798
17

OVACOME
Notes to the accounts for the year ended 30 September 2025
3 Income from Charitable Actiwties
Unrestricted
Restricted Total Funds Total Funds
Funds
Funds
2025
2024
Charitable activities - Fundraising
256,239
18,802
275,041
281,652
256,239
18,802
275,041
281,652
4 Fundraising Expenditure
Unrestricted
Restricted Total Funds
Total Funds
Funds
Funds
2025
2024
Direct Fundraising Expenses
Fundraising Costs
Fundraising Materials
Share of staff C05t Inote 6.11
Share of Support Costs (note 6.21
41.107
6,146
127.123
25.202
41,107
6,146
127,123
25.202
35,646
7,897
91,904
16,251
Total expenditure
199.578
199,578
151,698
5 Total charital￿e Expenditure
Unrestrirted
Funds
Restricted Totsl Fund5 Totsl Funds
Funds
2025
2024
Direct Charitsble Expenses
Event Costs
Website
35.505
15,850
4,051
35.505
15.940
4.588
27,214
10,311
3,546
90
Financial Assistance Members &
537
Partner group
Information Materials
Database and Membership
Magazine
Reach Ova resources
Film Resources and Photography
PR Costs
Raising Awareness Costs
Miscellaneous Costs
Share of staff Cost Inote 6.11
Share of SuptK)rt Costs (note 6.21
2.302
11.198
28.998
5.185
550
6.985
9.287
11.198
42.467
8.938
4.727
576
10,164
5,045
579.462
118,255
7,927
10,997
47,219
3,098
1,045
502
3,198
3,336
577,328
108,299
13,469
3,753
4.177
576
3,228
2,881
219,326
46,860
6.936
2.164
360.136
71.395
Total expenditure
489,491
356,661
846,152
804,020
18

OVACOME
Notes to the accounts for the year ended 30 September 2025
6 Staff Costsl6.11
Unrestricted
Restricted Total Funds
Funds
2025
Total Funds
2024
Funds
Wages & Salarie5
Social Security Costs
Pension Cost
410.556
63.270
13.433
219,326
629,882
63,270
13.433
599,546
57,330
12,356
487,259
219,326
706,585
669,232
Staff Cost allocated to:
Fundraising costs
Charitsble activities costs
127.123
360.136
487.259
127,123
579,462
706,585
91.904
577,328
669,232
219,326
219,326
2025
2024
Stsff Numbers laverage number of stsff)
17
17
No trustees received reimbursed expenses in the year12024- nil)
The number of employees whose employee benefits (excluding employers pension costl
exceeded £ 60,000 was:
2025
2024
£ 60001 to £ 70000
£ 70001 to £ 80000
£ 8(K)01 to £ 91)000
Trustees were not paid remuner3tion in either period.
Key management personnel include the Trust￿5 and the Chief Executive. The totsl employee benefits
(including gross pay and employer national insurance contributions) of the charity's key management
personnel were £89,01412024= £88.7931. Pension contributions paid by the company to key
management personnel totalled £1.32112024..£1.3211. Excluding the trustees there was one key
management personnel12024= one) that received remuneration during the year.
Under FRS 102. employee benefits include gross salary. employers national Insurance.
employers pension contributions and benefits in kind.
19

OVACOME
Notes to the accounts for the year ended 30 September 2025
6 Support Costs (6.21
Unrestricted Restricted Total Funds Total Funds
Funds
Funds
2025
2024
Rent
Printing and Ststionary
Office Cost
Profession31 fee
IT and computer Cost
Insurance
Depreciation
Staff training and support
Social media and advertising
Governance costs (Note 6.31
15,152
1.589
11,992
11.208
17,597
2,533
io,iio
1.438
4,501
25,262
3.027
16,493
11,208
28,542
2.533
21,687
3,457
15,261
10,568
23,024
2,453
1,468
21,365
20,847
4,420
124,550
10.945
26,265
1,814
4,899
96,597
14.598
5.268
40.863
7.082
4,899
143.457
Support Cost albcated to:
Fundraising costs
Charitsble activities costs
25,202
71,395
9&597
25,202
118,255
143,457
16,251
108,299
124,550
46,860
6 Governance Costs {6.3)
Unrestricted Restricted Totsl Funds Total Funds
Funds
Funds
2025
2024
Independent Examinefs fee
TR Accounts and ￿dit support
AGM and other ewenses
2,551
1,847
501
4,899
2,551
1,847
501
4,899
2,282
1,616
522
4,420
20

OVACOME
Notes to the accounts for the year ended 30 September 2025
7 TANGIBLE FIXED ASSETS
Computer
Mascot costume
Total 2025
Cost
At 1st Oct 2024
Additions
15.981
2,890
18.871
At 30 Sep 2025
15.981
2,890
18,871
Depreciation
At 1st Oct 2024
Provided during year
11,836
3,171
2,513
377
14,349
3,548
At 30 Sep 2025
15.(K)7
2,890
17,897
Net book value
At 30 Sep 2025
974
974
At 1st Oct 2024
4,145
377
4,522
DEBTORS
2025
2024
Prepayments and accrued income
15,090
11,179
15,090
11.179
CREDITORS: amounts falling due within one year
2025
2024
Deferred Income
Trade creditors
Grant payable
Accruals
Other Creditors
9,115
36,773
7,427
4,157
2,673
60,145
83.509
25,945
7,427
3.800
2,835
123,516
21

OVACOME
Notes to the accounts for the year ended 30 September 2025
10 ANALYSIS OF FUNDS
2025
Balance 30
Fund5 Balance 30
Income
Sep 2024
Expenditure
transfer
Sep 2025
Restrirted Funds
Support services
Staying Connected
OVA to You
Education
Regional Support
Reach OVA
460
4,660
8,051
102,721
84,713
80,975
195.3711
148,6621
171.1171
13,CK)01
137,2921
1101.2191
7.810
40,711
17.909
16.0(K)
26,969
46.263
102,009
24,971
29.943
2.184
Sub-tot31 Restricted funds
56.140
419.681
1356,6611
2.184
121,344
Unrestricted Funds
General Fund
395 249
457 903
689.069
161899
Designated Funds -
Research Fund
Sub-totsl Designated funds
36.765
36,765
36,765
36,765
Total funds
488.154
877,584 11.045,7301
320,￿8
Support services: We received funding towards the direct costs of our support services for those
affected by ovarian cancer. Thank you for the support we received from BEAT: Cancer. Thank you
for the funding from the Greenhall Foundation towards equipment.
Stsying connected: We received funding towards our programme of online support, information.
and activities for people affected by ovarian cancer. Thank you for the support from Sport England
and Samuel Gardner Memorial Trust.
Ova to You: We received funding to enable Ovacome to run monthly support events across the
UK. Thank you for the funding from National Lottery Awards for All Northern Ireland programme,
National Lottery Awards for All England programme, Oakdale Trust, Childwick Trust, London
Freemasons.
Education: We received funding towards our education programme for medical students and
healthcare professionals.
Regional support: We received funding towards the continuation of our regional sUPPOrt services.
Thank you for the support from the National Lottery Awards for All Scotland programme.
Reach OVA-. We received funding towards our work to provide support and information to those
who are less well represented within our membership and to those who experience addition31
health inequ31ities. These include but are not limited to-.
Those who are LGBTQIA+
Individuals and community groups that support people of colour andlor ethnic groups
other than white.
Those over the age of 75 or under 45 at point of diagnosis.
Those who are experiencing financial hardship or who have a low income.
Those who are rurally isolated.
22

OVACOME
Notes to the accounts for the year ended 30 September 2025
Those from Gypsy Roma Traveller Showmen and Boatmen communities.
Those who have a learning disability and/or are neurodivergent.
This funding has been used as per the restrictions to provide specialist resources and targeted
groups and campaigns. Thank you for the funding from Zurich Community Trust to support this
work.
ANALYSIS OF PRIOR YEAR FUNDS
2024
Balar￿e 30
Funds Balance 30
Sep 2023
I￿oMe ExpeNliture
transfer
Sep 2024
Restricted FurKIs
Support services
Staying Connected
Choir
OVA to You
Education
Regional Support
Reach OVA
Patient's Perspective
Core costs
Sub-total Restricted funds
14.868
73.973
9.160
{88,3811
14,5001
(1,4981
{22.9491
1551
{15,2401
1106,9491
{33,893
15,448
1278,9131
460
4,660
1.498
31.¢XIO
55
31.240
33.909 100.009
29.945
3.948
5.428
20
85,648 249,405
8,051
16,000
26,969
56,140
Unrestricted Funds
General Fund
576 618 495 436
676 805
395 249
Designated Funds -
Research Fund
Sub-total Designated funds
36.765
36,765
36,765
Total funds
699.031 744.841 1955.7181
488.154
23

OVACOME
Notes to the accounts for the year ended 30 September 2025
11 ANALYSIS OF NET ASSETS BY FUNDS
Unrestricted Fund Restrirted Fund Total Fund 2025
Fixed assets
Current assets
Current liabilities
974
257.835
160.1451
974
379,179
160,1451
121,344
Net assets 2025
320 008
Unrestricted Fund Restricted Fund Total Fund 2024
Fixed assets
Current assets
Current liabilities
4.522
551,008
1123.5161
4.522
607,148
1123.5161
56,140
Net 355ets 2024
432.014
488 154
12 OPERATING LEASE COMMITMENTS
At 30 September 2025 the charity had future minimum commitments in respect of non-
cancellable operating leases as follows
2025
2024
Rental expenses
Not later than l year
9,852
9,852
Total
13 RELATED PARTY TRANSACTIONS
The charity received donations from related parties £1,33412024: £2,096).
During the year, the charity received a loan of £IO,(KKI from a trustee which was fully repaid
before the year end. The loan was interest free and unsecured. No balance was outstsnding
at the reporting date.
24